Topical azithromycin shows benefit in mixed dry eye disease
Topical azithromycin ophthalmic solution (Azyter, 15 mg/g) significantly improved disease symptoms and signs as second-line treatment for mixed dry eye disease (DED), according to a study. The prospective controlled pilot…